Boulware, L. E. et al. Combating structural inequities—diversity, equity, and inclusion in clinical and translational research. N. Engl. J. Med. 386, 201–203 (2022).
Google Scholar
Oyer, R. A. et al. Increasing racial and ethnic diversity in cancer clinical trials: an American Society of Clinical Oncology and Association of Community Cancer Centers joint research statement. J. Clin. Oncol. 40, 2163–2171 (2022).
Google Scholar
Wendler, D. et al. Are racial and ethnic minorities less willing to participate in health research? PLoS Med. 3, e19 (2006).
Google Scholar
Frayne, S. M., Burns, R. B., Hardt, E. J., Rosen, A. K. & Moskowitz, M. A. The exclusion of non-English-speaking persons from research. J. Gen. Intern. Med. 11, 39–43 (1996).
Google Scholar
Glickman, S. W. et al. Perspective: The case for research justice: inclusion of patients with limited English proficiency in clinical research. Acad. Med. 86, 389–393 (2011).
Google Scholar
Muthukumar, A. V., Morrell, W. & Bierer, B. E. Evaluating the frequency of English language requirements in clinical trial eligibility criteria: a systematic analysis using ClinicalTrials.gov. PLoS Med. 18, e1003758 (2021).
Google Scholar
Roy, M. et al. Limited English proficiency and disparities in health care engagement among patients with breast cancer. JCO Oncol. Pract. 17, e1837–e1845 (2021).
Google Scholar
Fleurence, R. L. et al. Engaging patients and stakeholders in research proposal review: the patient-centered outcomes research institute. Ann. Intern. Med. 161, 122–130 (2014).
Staples, J. N. et al. Language as a barrier to cancer clinical trial accrual: assessing consenting team knowledge and practices for cancer clinical trial consent among low English fluency patients. Appl. Cancer Res. 38, 14 (2018).
Google Scholar
Clark, L. T. et al. Increasing diversity in clinical trials: overcoming critical barriers. Curr. Probl. Cardiol. 44, 148–172 (2019).
Google Scholar
Corbie-Smith, G., Miller, W. C. & Ransohoff, D. F. Interpretations of ‘appropriate’ minority inclusion in clinical research. Am. J. Med. 116, 249–252 (2004).
Google Scholar
Davis, T. C., Arnold, C. L., Mills, G. & Miele, L. A qualitative study exploring barriers and facilitators of enrolling underrepresented populations in clinical trials and biobanking. Front. Cell Dev. Biol. 7, 74 (2019).
Google Scholar
Murthy, V. H., Krumholz, H. M. & Gross, C. P. Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA 291, 2720–2726 (2004).
Google Scholar
Parada, H. Jr., Vu, A. H., Pinheiro, P. S. & Thompson, C. A. Comparing age at cancer diagnosis between Hispanics and non-Hispanic whites in the United States. Cancer Epidemiol. Biomarkers Prev. 30, 1904–1912 (2021).
Google Scholar
FDA takes important steps to increase racial and ethnic diversity in clinical trials. US FDA https://www.fda.gov/news-events/press-announcements/fda-takes-important-steps-increase-racial-and-ethnic-diversity-clinical-trials (2022).
Unger, J. M., Vaidya, R., Hershman, D. L., Minasian, L. M. & Fleury, M. E. Systematic review and meta-analysis of the magnitude of structural, clinical, and physician and patient barriers to cancer clinical trial participation. J. Natl Cancer Inst. 111, 245–255 (2019).
Google Scholar
Vuong, I. et al. Overcoming barriers: evidence-based strategies to increase enrollment of underrepresented populations in cancer therapeutic clinical trials—a narrative review. J. Cancer Educ. 35, 841–849 (2020).
Google Scholar
Ford, J. G. et al. Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review. Cancer 112, 228–242 (2008).
Google Scholar
Durant, R. W. et al. Perspectives on barriers and facilitators to minority recruitment for clinical trials among cancer center leaders, investigators, research staff, and referring clinicians: enhancing minority participation in clinical trials (EMPaCT). Cancer 120, 1097–1105 (2014).
Google Scholar
Selected characteristics of the foreign-born population by period of entry into the United States. US Census Bureau https://data.census.gov/cedsci/table?q=AMERICAN%20COMMUNITY%20SURVEY&tid=ACSST5Y2020.S0502 (2020).
Jones, N., Marks, R., Ramirez, R. & Rios-Vargas, M. 2020 census illuminates racial and ethnic composition of the country. US Census Bureau https://www.census.gov/library/stories/2021/08/improved-race-ethnicity-measures-reveal-united-states-population-much-more-multiracial.html (2021).
2019: ACS 1-year estimates selected population profiles. US Census Bureau https://data.census.gov/table?q=Language+Spoken+at+Home&tid=ACSST1Y2019.S1601 (2019).
Zeigler, K. & Camarota, S. A. 67.3 million in the United States spoke a foreign language at home in 2018. Center for Immigration Studies https://cis.org/Report/673-Million-United-States-Spoke-Foreign-Language-Home-2018 (2019).
Department of Health, Education, and Welfare; National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research The Belmont Report. Ethical principles and guidelines for the protection of human subjects of research. J. Am. Coll. Dent. 81, 4–13 (2014).
A guide to informed consent. US FDA https://www.fda.gov/regulatory-information/search-fda-guidance-documents/guide-informed-consent (1998).
Klitzman, R. How US institutional review boards decide when researchers need to translate studies. J. Med. Ethics 40, 193–197 (2014).
Google Scholar
McMillan, G. IRB policies for obtaining informed consent from non-English-speaking people. Ethics Hum. Res. 42, 21–29 (2020).
Google Scholar
Association, A. T. What is a certified translation? American Translators Association https://www.atanet.org/client-assistance/what-is-a-certified-translation/ (2023).
Mistretta, S. Amending federal regulations to counteract language barriers in the informed consent process. Voices Bioethics https://doi.org/10.52214/vib.v8i.8815 (2022).
Resnik, D. B. & Jones, C. W. Research subjects with limited English proficiency: ethical and legal issues. Account. Res. 13, 157–177 (2006).
Google Scholar
Spiegel, M. L. et al. Non-small cell lung cancer clinical trials requiring biopsies with biomarker-specific results for enrollment provide unique challenges. Cancer 123, 4800–4807 (2017).
Google Scholar
Informed consent, draft guidance for IRBs, clinical investigators, and sponsors. US FDA https://www.fda.gov/regulatory-information/search-fda-guidance-documents/informed-consent#nonenglish (2014).
Abadie, A. in Encyclopedia of Social Measurement (ed. Kempf-Leonard, K.) 259–266 (Elsevier, 2005).
Fundytus, A. et al. Industry funding of oncology randomised controlled trials: implications for design, results and interpretation. Clin. Oncol. (R. Coll. Radiol.) 34, 28–35 (2022).
Google Scholar
Bodenheimer, T. Uneasy alliance — clinical investigators and the pharmaceutical industry. New Engl. J. Med. 342, 1539–1544 (2000).
Califf, R. M. et al. Characteristics of clinical trials registered in ClinicalTrials.gov, 2007–2010. JAMA 307, 1838–1847 (2012).
Google Scholar
Ehrhardt, S., Appel, L. J. & Meinert, C. L. Trends in National Institutes of Health funding for clinical trials registered in ClinicalTrials.gov. JAMA 314, 2566–2567 (2015).
Google Scholar
Hakoum, M. B. et al. Characteristics of funding of clinical trials: cross-sectional survey and proposed guidance. BMJ Open 7, e015997 (2017).
Google Scholar
Nevens, H. et al. Budgeting of non-commercial clinical trials: development of a budget tool by a public funding agency. Trials 20, 714 (2019).
Google Scholar
Marshall, A. Principles of Economics: An Introductory Volume 8th edn (Macmillan, 1920).
Fischer, A., Conigliaro, J., Allicock, S. & Kim, E. J. Examination of social determinants of health among patients with limited English proficiency. BMC Res. Notes 14, 299 (2021).
Google Scholar
Proctor, K., Wilson-Frederick, S. M. & Haffer, S. C. The limited English proficient population: describing medicare, medicaid, and dual beneficiaries. Health Equity 2, 82–89 (2018).
Google Scholar
Quick facts. US Census Bureau https://www.census.gov/quickfacts/fact/table/US# (2022).
Schilsky, R. L. Publicly funded clinical trials and the future of cancer care. The Oncologist 18, 232–238 (2013).
Google Scholar
NIH policy and guidelines on the inclusion of women and minorities as subjects in clinical research. NIH https://grants.nih.gov/policy/inclusion/women-and-minorities/guidelines.htm (1993).
Schmidt, C. Cooperative groups say NCI trials funding inadequate; some turn to industry. J. Natl Cancer Inst. 99, 830–837 (2007).
Google Scholar
Txabarriaga, R. IMIA Guide on Medical Translation, https://www.imiaweb.org/uploads/pages/438.pdf (IMIA, 2009); .
Brelsford, K. M., Ruiz, E. & Beskow, L. Developing informed consent materials for non-English-speaking participants: an analysis of four professional firm translations from English to Spanish. Clin. Trials 15, 557–566 (2018).
Google Scholar
Staff, A. C. California: 2020 census. US Census Bureau https://www.census.gov/library/stories/state-by-state/california-population-change-between-census-decade.html#:~:text=Race%20and%20ethnicity%20(White%20alone,or%20More%20Races%2010.2%25) (2020).
Harris, P. A. et al. The REDCap consortium: building an international community of software platform partners. J. Biomed. Inform. 95, 103208 (2019).
Google Scholar
Harris, P. A. et al. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J. Biomed. Inform. 42, 377–381 (2009).
Google Scholar